Cyclin E as a potential therapeutic target in high grade serous ovarian cancer von Kanska, J, Zakhour, M, Taylor-Harding, B, Karlan, B.Y, Wiedemeyer, W.R

Volltext

YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14 von Huang, J-M, Nagatomo, I, Suzuki, E, Mizuno, T, Kumagai, T, Berezov, A, Zhang, H, Karlan, B, Greene, M I, Wang, Q

Volltext

Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway von Thoennissen, N H, O'Kelly, J, Lu, D, Iwanski, G B, La, D T, Abbassi, S, Leiter, A, Karlan, B, Mehta, R, Koeffler, H P

Volltext

Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer von Wolf, I, Levanon-Cohen, S, Bose, S, Ligumsky, H, Sredni, B, Kanety, H, Kuro-o, M, Karlan, B, Kaufman, B, Koeffler, H P, Rubinek, T

Volltext

Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy von Powell, C.B., Swisher, E.M., Cass, I., McLennan, J., Norquist, B., Garcia, R.L., Lester, J., Karlan, B.Y., Chen, L.

Volltext

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer von Davidson, T.M., Lebreton, C.L., Hendricksen, A.E. Wahner, Atkinson, H.J., Larson, M.C., Oberg, A.L., Provencher, D.M., Glaspy, J.A., Karlan, B.Y., Slamon, D.J., Konecny, G.E., Ray-Coquard, I.L.

Volltext

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions von Lancaster, Johnathan M, Powell, C. Bethan, Kauff, Noah D, Cass, Ilana, Chen, Lee-May, Lu, Karen H, Mutch, David G, Berchuck, Andrew, Karlan, Beth Y, Herzog, Thomas J

Volltext

Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ov... von Konecny, G.E., Hendrickson, A.E. Wahner, Davidson, T.M., Winterhoff, B.J., Ma, S., Mahner, S., Sehouli, J., Fasching, P.A., Feisel-Schwickardi, G., Poelcher, M., Roman, L.D., Rody, A., Karlan, B.Y., Mullany, S.A., Chen, H., Ray-Coquard, I.L., Provencher, D.M., Yachnin, A., Cottu, P.H., Glaspy, J.A., Haluska, P., Slamon, D.J.

Volltext

Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles von Ioffe, Y.J, Li, A.J, Walsh, C.S, Karlan, B.Y, Leuchter, R, Forscher, C, Cass, I

Volltext

Activated stromal mast cells in high grade serous ovarian cancers (HGSC) are associated with poor overall survival von Hodeib, M, Walsh, C, Knudsen, B, Karlan, B

Volltext

Coexisting ovarian malignancy in young women with endometrial cancer von WALSH, Christine, HOLSCHNEIDER, Christine, HOANG, Yen, TIEU, Khai, KARLAN, Beth, CASS, Ilana

Volltext

Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment von Taylor-Harding, B, Agadjanian, H, Nassanian, H, Kwon, S, Guo, X, Miller, C, Karlan, B Y, Orsulic, S, Walsh, C S

Volltext

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma von McIntosh, M.W., Drescher, C., Karlan, B., Scholler, N., Urban, N., Hellstrom, K.E., Hellstrom, I.

Volltext

BRCA1 promoter region hypermethylation in ovarian carcinoma : A population-based study von BALDWIN, Rae Lynn, NEMETH, Elizabeta, HANG TRAN, SHVARTSMAN, Hyun, CASS, Ilana, NAROD, Steven, KARLAN, Beth Y

Volltext

Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin von Wolf, I, Laitman, Y, Rubinek, T, Abramovitz, L, Novikov, I, Beeri, R, Kuro-O, M, Koeffler, H P, Catane, R, Freedman, L S, Levy-Lahad, E, Karlan, B Y, Friedman, E, Kaufman, B

Volltext

Vaginal high-grade sarcoma in pregnancy von Akametalu, P., Barcelon, J.M., Myint, O., Moatamed, N.A., Karlan, B.Y., Kamrava, M., Cohen, J.G.

Volltext

Improved survival in women with BRCA‐associated ovarian carcinoma von Cass, Ilana, Baldwin, Rae Lynn, Varkey, Taz, Moslehi, Roxana, Narod, Steven A., Karlan, Beth Y.

Volltext

The prognostic significance of ADAM metallopeptidase domain 12 in advanced stage serous ovarian cancer von Li, A, Cheon, D, Karlan, B, Orsulic, S

Volltext

Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis von Gozo, M C, Aspuria, P-J, Cheon, D-J, Walts, A E, Berel, D, Miura, N, Karlan, B Y, Orsulic, S

Volltext

The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first‐degree relative with breast cancer von Metcalfe, K.A., Lubinski, J., Gronwald, J., Huzarski, T., McCuaig, J., Lynch, H.T., Karlan, B., Foulkes, W.D., Singer, C.F., Neuhausen, S.L., Senter, L., Eisen, A., Sun, P., Narod, S.A.

Volltext